================================================================================
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 10, 2000
EMPYREAN BIOSCIENCE, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Wyoming 0-27839 86-0973095
---------------------------- ----------- -------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
23800 Commerce Park Road, Suite A, Cleveland, Ohio 44122
-------------------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (216) 360-7900
--------------------------------------------------------------
(Former name or former address, if changed since last report.)
================================================================================
<PAGE>
EMPYREAN BIOSCIENCE, INC.
ITEM 5. OTHER EVENTS
On August 9, 2000, the Company settled all outstanding legal disputes
between the Company and International Bioscience Corporation (IBC), and
announced the formation of a joint venture company with IBC. The Company issued
a press release with respect to the settlement and the joint venture on August
10, 2000. The press release is attached to this report as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
C. Exhibits
10.12 Settlement Agreement between Empyrean and IBC dated August
9, 2000.
10.13 Joint Venture Agreement between Empyrean and IBC dated
August 9, 2000.
10.14 IBC-Empyrean, L.L.C. Operating Agreement dated August 9,
2000.
10.15 Put Agreement between IBC and Empyrean dated August 9, 2000.
10.16 Nonqualified Stock Option Agreement between Empyrean and IBC
dated August 9, 2000.
10.17 Voting Agreement between Lawrence D. Bain and IBC dated
August 9, 2000.
10.18 License Agreement from IBC to Empyrean dated August 9, 2000.
10.19 Trademark License from IBC to Empyrean dated August 9, 2000.
10.20 Trademark License from Empyrean to IBC-Empyrean LLC dated
August 9, 2000.
10.21 Trademark License from Empyrean to IBC dated August 9, 2000.
99.1. Press release dated August 10, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EMPYREAN BIOSCIENCE, INC.
(Registrant)
8/17/00 /s/ Richard C. Adamany
------- ----------------------------------------
(Date) (Signature)
Richard C. Adamany
President and Chief Executive Officer
